Epilepsy Surgery and Neurostimulation: What Changes When Medication Alone Is Not Enough

The pill organizer on the kitchen counter has seven compartments, and each one now holds a third different medicine. The first two were taken faithfully, adjusted patiently, and still the seizures came: in the shower, at a nephew’s birthday, once at a red light with the engine running. At the last appointment the neurologist used a phrase that lands differently from anything said before. It is time to talk about epilepsy surgery when medication fails.

For most people that sentence arrives with a jolt, followed quickly by questions that feel too big for a fifteen-minute visit. Does this mean the medicines were the wrong ones? Is brain surgery really safer than another tablet? What is a stimulator, and how is it different from an operation?

This explainer walks through what actually changes at this point: how specialists decide who might benefit, what the evaluation involves, which options exist beyond the operating table, and what the honest evidence says about outcomes, risks, and the weeks that follow.

What happens when seizure medication doesn't work?

The first thing that happens is a pause, not a rush to the operating room. A neurologist who hears that seizures have continued through two medicines asks a set of questions before anything else. Were the doses reached in full? Were tablets missed, or timed unevenly around shift work? Is sleep loss, alcohol, or a new medicine lowering the threshold? Are the events actually epileptic seizures at all? Roughly one in four people referred to specialist epilepsy centers turn out to have events that look like seizures but have a different cause, such as fainting or dissociative episodes, which is why video EEG monitoring (recording brain waves and video at the same time) is often the very next step.

If the diagnosis holds and the medicines were fair trials, the condition earns a specific label. The International League Against Epilepsy defines drug-resistant epilepsy as failure of two tolerated, appropriately chosen, and appropriately used anti-seizure medicines, whether alone or in combination, to achieve sustained freedom from seizures. The definition matters because it functions as a trigger: it signals that the odds of a third or fourth medicine solving the problem are modest, and that the person should be seen at a center able to assess options other than tablets.

Those options fall into three families. Resective surgery removes the small area of brain where seizures begin. Disconnective surgery cuts the pathways seizures use to spread. Neurostimulation leaves the brain intact and uses gentle electrical pulses to make seizures less likely or shorter. None of these is a substitute for good medical care; most people continue medicines for a time even after a successful procedure, as later sections explain.

Why epilepsy surgery when medication fails is discussed sooner than most people expect

Many families assume surgery is the last resort, reserved for people who have tried every medicine on the shelf. The evidence points the other way. A landmark study of 470 people newly diagnosed with epilepsy, published in the New England Journal of Medicine and indexed on PubMed, found that 47 percent became seizure free on their first well-chosen medicine. Of those who did not, only 13 percent responded to a second medicine, and just 4 percent to a third or to combinations. Each failed trial lowers the chance that the next one will work.

That steep drop is why guideline bodies encourage referral for surgical evaluation once two medicines have failed, rather than after five or six. The word evaluation deserves emphasis. Being referred does not commit anyone to an operation; it opens a diagnostic process that often changes the medical plan even when no surgery follows. A clearer picture of seizure type can lead to a better-matched medicine, and some people are found to have a syndrome where stimulation makes more sense than resection.

Time also matters biologically and socially. Ongoing seizures carry a small but real risk of injury and of sudden unexpected death in epilepsy, discussed later, and they shape driving, employment, and independence. The NHS notes that surgery is considered when medicines are not controlling seizures and tests show the seizures come from a small, identifiable part of the brain that can be removed without harming important functions. The sooner that question is asked, the sooner a person knows whether they are one of the people for whom it applies.

How epilepsy surgery actually works: finding and treating the seizure focus

Picture a house with faulty wiring in one room. Every so often a spark there trips the whole building. You could keep replacing fuses, or you could find the room and fix the circuit. Focal epilepsy behaves like that house: seizures start in a limited region called the seizure focus, then spread along normal connections. Surgery aims to remove, disconnect, or dampen that region while leaving the rest of the wiring untouched.

Finding the room is the hard part, and it is where most of the work happens. The team layers several kinds of evidence. Scalp EEG shows the electrical signature of seizures and roughly where they begin. High-resolution MRI looks for structural causes such as hippocampal sclerosis (scarring in a memory structure deep in the temporal lobe), cortical dysplasia (a patch of brain that formed slightly abnormally before birth), or small tumors and blood vessel malformations. PET scanning can reveal an area that uses less sugar between seizures, a clue to dysfunction even when the MRI looks normal. Neuropsychological testing maps memory and language, so the team knows what sits near the target.

When these lines of evidence agree, surgeons can plan a resection with confidence. When they disagree, or when the focus sits near speech or movement areas, electrodes may be placed directly on or into the brain for days of recording, a step called intracranial or stereo-EEG monitoring. Only when the focus is located and judged safe to treat does the conversation turn to which procedure fits. The Mayo Clinic describes this sequence as the standard pathway, and it explains why an evaluation can take months rather than weeks.

Which types of epilepsy surgery and neurostimulation are there?

The menu is wider than most people realize, and the right entry depends on where seizures start, how many places they start from, and what function lives nearby. The table below summarizes the main procedures in plain terms; details of each appear in the sections that follow.

Procedure	What is done	Usually considered when
Temporal lobe resection	Removal of the front and inner part of one temporal lobe, including scarred memory structures	Seizures begin in one temporal lobe, the most common focal pattern in adults
Lesionectomy or focal cortical resection	Removal of a defined abnormal patch, such as a dysplasia or small tumor	A single lesion matches the EEG findings and sits away from critical areas
Laser interstitial thermal therapy	A thin fiber heats and destroys a small target under MRI guidance through a small skull opening	A small, deep, well-defined focus, often as an alternative to open resection
Corpus callosotomy	Cutting the bridge of fibers between the two hemispheres	Drop attacks or generalized seizures that cannot be traced to one focus
Hemispherotomy	Disconnecting one damaged hemisphere from the rest of the brain, mainly in children	Severe seizures from one hemisphere that is already badly injured
Vagus nerve stimulation	A pulse generator under the collarbone stimulates the vagus nerve in the neck	Focus cannot be safely removed, or surgery is declined
Responsive neurostimulation	Electrodes on the focus detect seizure onset and deliver pulses to interrupt it	One or two foci in areas too important to remove
Deep brain stimulation	Electrodes in a deep relay nucleus deliver scheduled pulses	Multifocal or poorly localized focal epilepsy

Resective and ablative procedures offer the possibility of stopping seizures altogether because they remove the source. Disconnective and stimulation procedures are usually described as palliative in the medical sense: their goal is fewer, shorter, or less dangerous seizures rather than freedom from them. That distinction, more than the size of the incision, is what a person weighing options should understand first.

What is vagus nerve stimulation for epilepsy, and how does neurostimulation differ from surgery?

Neurostimulation is sometimes described as a pacemaker for the brain, and the comparison is fair as far as it goes. A small battery-powered generator is implanted under the skin and connected by thin wires to a nerve or to the brain itself. It delivers timed electrical pulses that change how excitable the affected networks are. Nothing is removed. The approaches differ in where the wires go and in whether the pulses are scheduled or triggered by detected activity.

Vagus nerve stimulation places the generator below the collarbone and wraps an electrode around the left vagus nerve, a long nerve running through the neck that carries signals between the brain and internal organs. The generator fires on a repeating cycle, and many devices also allow the person or a caregiver to trigger an extra burst with a magnet when a seizure begins. The Mayo Clinic notes that most people do not become seizure free with this approach; the realistic aim is a reduction in frequency or severity, which can take many months to become apparent, and that outcome is in addition to, not instead of, medicines.

Responsive neurostimulation places electrodes directly on the seizure focus. The device continuously listens, recognizes the electrical pattern that precedes a seizure, and delivers a brief pulse to disrupt it, often before the person feels anything. It is designed for people whose focus is known but sits in a region such as language cortex that cannot be removed safely. Deep brain stimulation places electrodes in the anterior nucleus of the thalamus, a relay station that seizures pass through, and stimulates on a fixed schedule.

The trade-off is straightforward. Stimulation carries no risk of removing healthy tissue and can be adjusted or switched off, but it rarely ends seizures completely. Resection carries the risk that comes with removing tissue, and offers the only realistic route to being seizure free.

Who is usually offered epilepsy surgery, and who is asked to wait?

Good candidates share a recognizable profile. Their seizures are focal, meaning they start in one place. The tests agree on where that place is. The area can be removed or disconnected without predictable loss of speech, movement, vision, or memory that the person would find unacceptable. Two or more medicines have genuinely been tried. The person, or in the case of a child the family, understands what the procedure can and cannot do and wants to proceed. When all of these line up, the National Institute of Neurological Disorders and Stroke describes surgery as an established and often underused option.

Children are not asked to wait simply because they are young. Some childhood syndromes worsen with time, and a developing brain can reorganize function after surgery more readily than an adult brain. Early referral in children with drug-resistant focal seizures is standard guideline advice.

Other people are asked to wait, or to consider stimulation instead. The most common reasons are seizures that arise from several independent regions; a focus that overlaps with essential function and cannot be safely resected; a diagnosis still in doubt after monitoring; or a generalized epilepsy syndrome, where seizures begin across both hemispheres at once and there is no single focus to target. A person whose medicine trials were cut short by side effects rather than by lack of effect may be offered a further, better-tolerated medical trial before evaluation continues.

Waiting is not the same as being refused. Imaging improves, new information emerges from a repeat monitoring stay, and a person who was not a candidate for resection may still be a candidate for stimulation. The decision belongs to a multidisciplinary conference, and it is reasonable to ask for its reasoning in writing.

What does the pre-surgical evaluation involve, step by step?

The evaluation is the part most people know least about and worry about least, yet it is where the real decisions are made. It typically unfolds in two phases.

Phase one is non-invasive. The centerpiece is admission to an epilepsy monitoring unit for continuous video EEG, often lasting several days. Medicines may be reduced under supervision so that a few typical seizures can be recorded; this is the only time reducing medicines is appropriate, and it happens with nurses, cameras, and rescue treatment at hand. Alongside monitoring come a high-resolution MRI using an epilepsy protocol, sometimes a PET scan, and a full day of neuropsychological testing. Some centers add functional MRI, in which the person performs language or memory tasks in the scanner so the team can see which hemisphere handles speech, or magnetoencephalography, which records the tiny magnetic fields produced by brain activity.

Phase two is needed only when phase one leaves doubt. Thin electrodes are placed through small openings in the skull, either resting on the brain surface or inserted along planned trajectories, and the person returns to the monitoring unit for another stay. Direct recording pinpoints the focus and allows brief stimulation to map function so surgeons know exactly what to avoid.

Every result is then presented at a case conference attended by neurologists, neurosurgeons, neuroradiologists, neuropsychologists, and nurses. The Mayo Clinic describes this team review as the point at which candidacy is decided. Expect the whole process to take months, expect some tests to be repeated, and expect to be asked more than once what outcome would make the risks worthwhile to you.

What is the most successful epilepsy surgery? What the trials actually show

People search this question hoping for a ranking. The honest answer is that success depends on matching the right procedure to the right person, but one procedure does carry the strongest evidence: resection for temporal lobe epilepsy, especially when MRI shows hippocampal sclerosis on one side.

The best-known trial, published in the New England Journal of Medicine and indexed on PubMed, randomly assigned 80 adults with drug-resistant temporal lobe epilepsy either to surgery or to another year of optimized medicines. After one year, 58 percent of the surgical group were free of seizures that impaired awareness, compared with 8 percent of the medical group. Quality of life scores also improved more in the surgical group. It remains the foundational evidence behind the recommendation to evaluate temporal lobe epilepsy early.

Outside the temporal lobe the picture is more mixed. Removing a well-defined lesion elsewhere in the cortex can also be highly effective when EEG and imaging agree, but when the MRI is normal, or the focus lies near critical function, freedom from seizures is less predictable and figures vary widely between studies. Laser ablation offers a smaller opening and faster recovery, and the trade-off reported in observational series is a somewhat lower likelihood of complete seizure freedom than open resection for the same target; comparative trial data are still limited.

Stimulation procedures should not be judged by the same yardstick. Their aim is reduction, and the improvement tends to grow over the first few years rather than appearing at once. If someone offers a single success percentage for epilepsy surgery in general, ask which procedure, which patients, and which definition of success it refers to. Your team will give you their own center’s figures for your specific situation.

What are the risks of epilepsy surgery and neurostimulation?

Any procedure that touches the brain carries risk, and a good consent conversation names each one specifically rather than gesturing at complications in general. Risks fall into three groups.

General surgical risks include bleeding, infection, blood clots, and reactions to anesthesia. Stroke is uncommon but possible with any brain operation, and its likelihood depends on the location and on individual anatomy.

Function-specific risks depend on what sits near the target. After temporal lobe resection on the language-dominant side, some people notice new difficulty recalling words or names, and verbal memory can decline; the neuropsychological testing done beforehand is designed to predict how large that change might be. Resections near the visual pathway can leave a blind patch in the upper outer corner of vision on one side, which many people do not notice in daily life but which can matter for driving rules. Surgery near motor cortex risks weakness. Mood changes, including low mood or anxiety in the months after surgery, are recognized and treatable, and screening for them is part of standard follow-up.

Device-specific risks apply to stimulation. Vagus nerve stimulation commonly causes hoarseness, cough, or a tingling in the throat while the device fires, effects that usually fade as settings are adjusted. Any implanted device can become infected, and wires can break or move, sometimes requiring revision. Batteries need replacement after several years. Deep brain and responsive stimulation involve electrodes placed within the skull and therefore carry a small risk of bleeding at insertion.

Against these must be set the risks of doing nothing. Uncontrolled seizures cause injuries, and drug-resistant epilepsy carries the higher mortality described later. The comparison is never surgery versus safety; it is one set of risks against another, weighed by a team that knows both well.

What do the days and weeks after epilepsy surgery usually look like?

The first night is typically spent in an intensive care or high-dependency unit for close observation, then on a neurosurgical ward. The Mayo Clinic describes a hospital stay of roughly three to four days after resective surgery, though this varies with the procedure and with how quickly someone is eating, walking, and managing pain.

Headache is expected and manageable in the first week or two. Swelling around the incision, mild jaw stiffness after temporal procedures, and profound tiredness are all common and settle gradually. Many people describe the fatigue as the surprise: an afternoon nap becomes non-negotiable for a few weeks. Staples or stitches are removed at the first clinic visit.

Seizures in the first days after surgery do happen and do not necessarily predict failure; irritated tissue can misfire while it heals. Medicines are continued unchanged through this period. The Mayo Clinic notes that most people return to work or school within about one to three months, with desk-based work at the shorter end and physically demanding jobs at the longer end. Driving remains prohibited until the seizure-free interval required by local law has passed, whatever the reason for the earlier seizures.

Laser ablation and stimulator implantation involve shorter stays, often one to two nights, and quicker return to routine, though stimulator settings are adjusted over a series of clinic visits and the full effect builds over months.

Follow-up typically includes a visit at a few weeks, then at intervals through the first year, with EEG and imaging as needed and repeat neuropsychological testing at some centers to document any changes. Rehabilitation such as speech therapy is arranged early if word-finding or memory changes appear.

Will I still need medication after surgery? Life after epilepsy surgery

Yes, at least for a while, and this catches many people off guard. Surgery removes the source of seizures, but the surrounding brain has spent years learning to generate them, and it needs time to settle. The Mayo Clinic advises that anti-seizure medicines are usually continued for at least a year or two after surgery, even when no seizures occur. Only then, and only if the person has remained seizure free, does the neurologist discuss whether a gradual, supervised reduction is reasonable. That conversation weighs the person’s job, driving needs, and tolerance for uncertainty, and any change is made by the prescribing clinician, never independently.

Some people never come off medicines entirely but find that fewer, or a lower burden, controls seizures that previously broke through everything. For those with stimulators, medicines remain part of the plan indefinitely; the device is a partner, not a replacement.

Life after epilepsy surgery has a shape that outcome statistics do not capture. People who become seizure free often describe a strange period of adjustment: learning to trust the body again, re-entering situations avoided for years, sometimes grieving time lost. Employment, driving, and independence typically improve, but the improvement is gradual and can strain relationships built around a caregiving role. Anxiety and depression can surface or lift in the months after surgery in either direction, which is why most centers screen for mood at each visit.

Follow-up never fully ends. Annual review, a plan for what to do if a seizure recurs, and awareness that late recurrence is possible even years later remain part of living well after a procedure, whichever one was chosen.

Life expectancy and survival with drug-resistant epilepsy: what the evidence says

Two questions appear constantly in searches: the survival rate of epilepsy surgery, and the life expectancy of someone with drug-resistant epilepsy. They deserve honest, separate answers.

Death directly caused by epilepsy surgery is uncommon in modern practice, but exact figures depend on the procedure, the center, and the person’s other health conditions. Any center should be able to share its own audited outcomes, and it is reasonable to ask for them rather than rely on a general number.

Life expectancy with uncontrolled seizures is the more important figure, because it frames what the surgery is trying to change. The World Health Organization reports that the risk of premature death in people with epilepsy is up to three times higher than in the general population, with the excess concentrated in those whose seizures are not controlled. Contributors include injuries and drowning during seizures, prolonged seizures called status epilepticus, and sudden unexpected death in epilepsy, known as SUDEP. SUDEP describes a death in a person with epilepsy that is not explained by injury, drowning, or another identified cause; it is most closely linked to frequent generalized tonic-clonic seizures, particularly those occurring during sleep. The National Institute of Neurological Disorders and Stroke identifies uncontrolled seizures as the strongest known risk factor.

This is the context in which surgery becomes a safety decision rather than merely a quality-of-life one. Reducing or ending convulsive seizures lowers exposure to the mechanisms behind these deaths. It is also why the WHO emphasizes that up to 70 percent of people with epilepsy could live seizure free if properly diagnosed and treated, a figure that includes surgical and medical care together, and why long delays in referral are increasingly viewed as a problem to be fixed rather than an unavoidable feature of the condition.

What people often get wrong about epilepsy surgery when medication fails

The myth: surgery means the medicines were a mistake. Failing two medicines is information, not a verdict on anyone’s choices. The trial data cited earlier show that most people who will respond to medicine do so early; the rest are not failures, they have a different kind of epilepsy that needs a different tool.

The myth: it is a last resort after every medicine is exhausted. Guidelines point in the opposite direction. Two adequate trials, not ten, is the threshold for evaluation. Years of additional trials rarely add benefit and do add years of risk.

The myth: agreeing to evaluation means agreeing to an operation. Evaluation is diagnostic. A meaningful share of people who enter it are found unsuitable for resection, and many others change their minds; both are legitimate endings.

The myth: a stimulator is a smaller version of surgery with similar results. Stimulation and resection have different goals. One aims to reduce seizures, the other to stop them. Choosing between them is about anatomy and priorities, not about bravery.

The myth: after surgery the medicines stop. They continue for at least a year or two, and sometimes indefinitely, with any change made by the prescribing clinician.

The myth: personality changes are inevitable. Mood shifts can occur and are monitored, but the targeted removal of a small, already dysfunctional region is not the same as the crude procedures of a past era that still shape public imagination.

The myth: a normal MRI rules surgery out. It makes localization harder, and the outcome less predictable, but PET, magnetoencephalography, and intracranial recording exist precisely for these cases. The right question is whether the focus can be found, not whether the scan is clean.

Questions to ask your care team about drug-resistant epilepsy treatment options

A surgical conference produces a recommendation, but the person living with the result deserves to understand how it was reached. Bring these questions to the visit where options are presented; writing the answers down in the room is easier than reconstructing them later.

• Where exactly do you believe my seizures start, and how confident is the team? Which tests agreed, and which did not?
• Which procedure are you recommending, and what is its goal for me: freedom from seizures, or fewer and milder seizures?
• What are the alternatives you considered and set aside, including stimulation, and why?
• What specific functions sit near the target, and what changes to memory, language, vision, or movement should I prepare for?
• What are this center’s own outcomes and complication rates for this procedure in people like me?
• How long will I stay in hospital, when can I expect to return to work or study, and what rehabilitation might I need?
• What is the plan for my medicines afterward, and when would a reduction even be discussed?
• What happens if the first procedure does not achieve its goal? Is a second evaluation possible?
• How will mood and mental health be monitored after surgery, and who do I contact if I am struggling?
• What does this mean for driving, work restrictions, pregnancy plans, or contraception?
• If I decide not to proceed now, what would change the picture in the future, and how often should I be reassessed?

Asking for time to think is expected. So is asking for a second opinion from another epilepsy center; experienced teams welcome it, because the decision is one a person carries for life, and a choice made with full understanding is a choice more easily lived with whatever the outcome.

When to call your doctor: red-flag signs before and after epilepsy surgery

Some situations need same-day advice or emergency care, whether a person is waiting for evaluation, recovering from a procedure, or years past it.

Call emergency services immediately if a seizure lasts longer than five minutes, if seizures follow one another without recovery in between, if breathing does not return to normal after a seizure, if a seizure happens in water, or if there is a significant injury. Prolonged seizures, known as status epilepticus, are a medical emergency at any stage of treatment.

After surgery, contact the surgical team urgently for fever, increasing redness, swelling or discharge at the incision, clear fluid leaking from the wound or nose, a headache that worsens steadily or does not respond to the recommended pain relief, new or worsening weakness, difficulty speaking or understanding speech, new confusion or unusual drowsiness, persistent vomiting, or a new problem with vision. Calf pain or swelling, chest pain, or sudden breathlessness in the weeks after any operation can signal a blood clot and need prompt assessment.

For those with an implanted stimulator, report persistent hoarseness that does not settle with adjustment, pain or swelling over the generator or along the wire, a sensation that the device has stopped working or feels different, or any planned MRI or other procedure so the team can confirm compatibility and settings beforehand.

At any point, a return of seizures after a seizure-free period, a change in the type of seizure, thoughts of self-harm, or a low mood that does not lift within a couple of weeks deserve a call rather than a wait for the next scheduled visit. Never adjust or stop anti-seizure medicines on your own; sudden changes can provoke severe seizures, and every adjustment belongs with the prescribing clinician.

Frequently asked questions

What happens when seizure medication doesn't work after two tries?

After two appropriately chosen medicines fail, the condition meets the definition of drug-resistant epilepsy and guidelines advise referral to a specialist epilepsy center for evaluation. That evaluation confirms the diagnosis, often with video EEG monitoring, and looks for a single seizure focus. Depending on the findings, the team may propose a better-matched medicine, a resective or ablative procedure, or neurostimulation. Referral is a diagnostic step, not a commitment to surgery.

What is the survival rate of epilepsy surgery?

Death caused directly by modern epilepsy surgery is uncommon, but the exact figure depends on the procedure, the person’s other health conditions, and the center, so ask your team for their own audited results rather than relying on a general number. The more relevant statistic is the other way around: the WHO reports that people with uncontrolled epilepsy face up to three times the risk of premature death of the general population.

What is the life expectancy of patients with drug-resistant epilepsy?

There is no single number, because it depends on seizure type, frequency, and other health factors. The excess risk is concentrated in people with frequent generalized convulsive seizures, through injury, prolonged seizures, and sudden unexpected death in epilepsy. Bringing convulsive seizures under control, whether by medicine, surgery, or stimulation, reduces exposure to those mechanisms, which is a central reason guidelines encourage early surgical evaluation.

What is the most successful epilepsy surgery?

Temporal lobe resection has the strongest evidence, particularly when MRI shows hippocampal sclerosis on one side. A randomized trial found 58 percent of surgical patients free of awareness-impairing seizures at one year compared with 8 percent on continued medicines. Other resections can also be effective when tests agree on the focus. Stimulation procedures are judged by seizure reduction rather than freedom, so they should not be ranked on the same scale.

How does vagus nerve stimulation for epilepsy work?

A small generator implanted below the collarbone sends timed electrical pulses along a wire to the left vagus nerve in the neck, which carries signals to seizure-related networks in the brain and makes them less excitable. Many devices also allow an extra burst to be triggered with a magnet when a seizure starts. It rarely stops seizures altogether; the aim is fewer or milder seizures alongside continued medicines, with benefit building over months.

What are the main drug-resistant epilepsy treatment options besides surgery?

Beyond resective surgery, options include neurostimulation such as vagus nerve, responsive, and deep brain stimulation; laser ablation, which destroys a small focus through a tiny skull opening; disconnective procedures for seizures that cannot be traced to one spot; and, in some children and adults, medically supervised dietary therapies such as ketogenic diets. A further, better-tolerated medicine trial is also sometimes reasonable. Your neurologist matches these to your seizure type.

What is life after epilepsy surgery really like?

Recovery involves a hospital stay of a few days, several weeks of fatigue and headache, and a return to work or study typically within one to three months. Medicines continue for at least a year or two. People who become seizure free often describe a gradual, sometimes emotionally complex adjustment to new independence, and mood is monitored because both improvement and low mood can occur. Follow-up continues long term, including a plan for any recurrence.

Can children have epilepsy surgery, and is it different from adults?

Yes. Children with drug-resistant focal seizures are evaluated on the same principles, and often earlier, because some syndromes worsen over time and a young brain can reassign functions after surgery more readily than an adult brain. Procedures range from focal resection to hemispherotomy for one severely damaged hemisphere. Preparation focuses on age-appropriate explanation, play specialists, and family involvement, and the team guides every step of recovery.

Do I have to stop my medicines to have the tests?

Only inside the epilepsy monitoring unit, and only under supervision. During video EEG admission, doctors may reduce medicines deliberately so that a few typical seizures can be recorded with nurses, cameras, and rescue treatment at hand. This is the sole setting in which reduction is appropriate. Outside the hospital, medicines are never stopped or changed for testing, and any adjustment is made by the prescribing clinician.

What if surgery is offered and I decide not to go ahead?

Declining is a legitimate choice, and it does not close the door permanently. Your neurologist will continue optimizing medical treatment, may discuss stimulation as a less invasive alternative, and should agree a schedule for reassessment, since imaging technology and your own priorities can change. A second opinion from another epilepsy center is reasonable at any stage, and experienced teams generally welcome it.

References

• Epilepsy and Seizures (National Institute of Neurological Disorders and Stroke, NIH)
• Epilepsy: Treatment (NHS)
• Epilepsy fact sheet (World Health Organization)
• A randomized, controlled trial of surgery for temporal-lobe epilepsy (PubMed, NIH)

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.